Abbas Mohammadi

Resident Physician @ValleyHealth | Former Scientist @Harvard & @BWH | CCU Dr @SUMS | ACC Medical Resident❤️‍🩹 | A.I | Health Advocate🩺 | IMG🇺🇸🇮🇷|🏀 Fan

[Gregg Fonarow MD @gcfmd]

💊❤️‍🩹 4 pillars of GDMT for HFrEF

none are optional, each one is a survival enhancing therapy

🔵 ARNI → ▼2.8% all-cause death

🫀 Beta-blocker → ▼ up to 5.6%

💧 MRA → ▼ up to 11%

🩸 SGLT2i → ▼2.3%

Leaving even one out ≠ neutral

Each benefits>>>potential risks

[Gregg Fonarow MD @gcfmd]

🚨💊 NEW in Nature Medicine: the POLY-HF trial 🫀

A once-daily HF polypill beat enhanced usual care 👇

📈 +3.3 pts LVEF (P=0.039)

🏥 60% ⬇️ HF hospitalizations/ED visits

💪 71% vs 42% on optimal GDMT

✅ 79% vs 54% adherence

🔗 https://t.co/ZqCMkStqGE

[Abbas Mohammadi @DrBase_AMD]

@MichaelDiCaroMD @DrBishev You guys are GREAT! Congratulations to both 🎉

[Abbas Mohammadi @DrBase_AMD]

🏃‍♂️New study: 150 min/week of exercise lowered CVD risk by ~8–9%, while >30% risk reduction required ~560–610 min/week. Higher VO₂max independently reduced cardiovascular risk, with genetic evidence supporting lower heart failure risk. #cardiology

https://t.co/EZP9O3BP2z

[Abbas Mohammadi @DrBase_AMD]

@masry_hicham Huge congratulations, Dr. El Masry! It’s fascinating that ischemic cardiomyopathy rates are identical between groups, really points toward an Lp(a)-driven myocardial fibrosis substrate rather than macrovascular CAD as the main arrhythmic driver. Brilliant work!

[Jennifer Kwan MD PhD @jennkwanMDPhD]

🧪58% early career phys-sci considering leaving research
📉72% cite $ instability as major driver
🌎43.9% considering leaving US for research abroad
🔥Burnout,⬇️research⏲️➡️attrition. Proud to partner w/@theNAMedicine for new phy-sci initiative https://t.co/xf5LKfctkg @AbushoukMD

[Allan L. Klein @AllanLKleinMD1]

You do not want miss this unique webinar from the newest special interest group from ASE. Outstanding presentations and world famous panel.

[Abbas Mohammadi @DrBase_AMD]

Received the 1st place award at the Las Vegas EKG Competition. Appreciate the UNLV team for hosting such a great educational event and the opportunity to learn from outstanding faculty and colleagues. #Cardiology #ECG #EKG

[Abbas Mohammadi @DrBase_AMD]

High benchmark scores ≠ real-world performance.

LLMs can get ~95% diagnostic accuracy alone, but users with the same tools identify conditions in <35% of cases—no better than usual sources.

The gap is human-AI interaction.
@NatureMedicine #acc2026 #AI
https://t.co/AJD4AWTcIx

[European Society of Cardiology Journals @ESC_Journals]

New in #EJPC:
✅ In statin-treated patients with well-controlled LDL-C undergoing percutaneous coronary intervention, residual inflammatory risk (alone or in combination with residual triglyceride risk) is associated with a higher incidence of MACE.
📕 https://t.co/XisgvMVXyG

#EJPC @EJPCEiC @AboyansV @SilCastelletti @PTBuketAkinci @PeroneFrancesco @SMosteoru @TimKambic #cvprev

[Gregg Fonarow MD @gcfmd]

@drbennisahmed @AndrewJSauer @robmentz @hvanspall @MKIttlesonMD @HFSA @SJGreene_md @mvaduganathan @JavedButler1 @JamesCFangMD @DLBHATTMD @ankeetbhatt If the current treatment gaps for MRA use were closed with optimal implementation globally….

207,181 lives could be saved each year

https://t.co/KvHcvVtV0k

[Abbas Mohammadi @DrBase_AMD]

🧵 New PAD review in @Heart_BMJ.

Bottom line: PAD is common, underdiagnosed, and mismanaged. We give you a practical framework, from GDMT to TADV, with guideline comparisons.

https://t.co/StRmnhzKT4

Thanks to my great mentor Dr. @shishem and amazing team Drs. Leen and Yahyavi

[American College of Cardiology @ACCinTouch]

The joint EAPC/ESC and ACC Clinical Consensus Statement provides an in-depth update on the current state of knowledge on abnormal cardiovascular findings in Masters athletes.

Read the journal scan for more 👉 https://t.co/WMmImNgRPG #SportsCardio #JACC

[BostonSci Cardiology @BSCCardiology]

As pacing strategies continue to evolve, the SYNCHRONICITY Trial is exploring whether left bundle branch area pacing (LBBAP) may offer an effective alternative to conventional CRT for HFrEF patients with left bundle branch block (LBBB).

Learn more about the study: https://t.co/0YpQJAnCFP

[American College of Cardiology @ACCinTouch]

What an incredible #ACC26! From cutting-edge LBCTs, to thought-provoking discussions, we learned, connected, and helped transform cardiovascular care worldwide. 🌎

Thank you to everyone who joined and made ACC.26 so memorable!

📅 See you next year in Houston for #ACC27!

[Abbas Mohammadi @DrBase_AMD]

3 #ACC26 highlights:

1️⃣ REDUCE-MFA: Anti-fibrotics show strong benefit post-TAVI (Win Ratio 1.64). 🫀
2️⃣ CLAiR AI: Retinal imaging predicts ASCVD (91% sensitivity). 👁️
3️⃣ Peter Libby: CAD and NLRP3 Inhibitor
VTX3232

Cardiology: from plumbing → precision biology
@ACCinTouch

[Abbas Mohammadi @DrBase_AMD]

Congratulations to Dr. Roxana Mehran on becoming the new ACC President! 👏

It was truly a pleasure to be at the ACC.26 Convocation, honestly felt like a dream being there and witnessing such an inspiring moment in cardiology.
#ACC2026 #ACC26 @Drroxmehran #cardiology @ACCinTouch

[Abbas Mohammadi @DrBase_AMD]

Big congratulations to the Massachusetts fellow for winning the #ACC.26 Jeopardy competition 🎉 proud moment for my home state! It was a close and exciting contest, beautifully led by Dr. @SaurabhSDani and Dr. @DocBrownAB @KannuBansalMD @ChrisKramerMD

[Abbas Mohammadi @DrBase_AMD]

Day 2 at #ACC.26: Another great day meeting amazing people and learning so much from their experiences. Grateful for every conversation and connection.
@ACCinTouch @CASivaram1 @MartyTamMD @RCardasco

[Abbas Mohammadi @DrBase_AMD]

Day 1 at #ACC.26: Both of my presentations went great, and I had the chance to connect with so many incredible people. Excited for what's next!
@ACCinTouch #cardiology #AI @adanielianmd @ATawakolMD @CNKanaan @AzarRadfar